CT-2103
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CT-2103, covering 2008-09-22 to 2013-05-30. Get the full timeline:
Most recent: Clinical Trial Update: CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1, Phase 2]